Artwork for podcast Lung Cancer Update
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Episode 29 • 18th August 2025 • Lung Cancer Update • Dr. Neil Love
00:00:00 00:17:44

Share Episode

Shownotes

Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. 

CME information and select publications here.

Follow

Links

Chapters

Video

More from YouTube